Understanding and managing burn pain: Part 2.
Despite advances in treatment of burn injuries and their consequent pain, wound care is the main source of the pain associated with burn injury. This two-part article explores burn pain and its treatment from a nursing perspective. Last month, Part 1 provided an overview of burn injury and addressed the wound care-related causes of burn pain, as well as its assessment and treatment. Part 2, presented here, provides a more in-depth discussion of pain management; topical medications and the psychological aspects of burn pain are also discussed.
Connor-Ballard
Patricia A
PA
Inova Learning Network, Inova Health System, Northern Virginia, USA. patricia.connor-ballard@inova.org
D000208:Acute Disease; D000698:Analgesia; D000700:Analgesics / Q000627:therapeutic use; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use; D002056:Burns / Q000150:complications* / Q000523:psychology; D002266:Carboxymethylcellulose Sodium / Q000627:therapeutic use; D015984:Causality; D016903:Drug Monitoring / Q000451:nursing; D004359:Drug Therapy, Combination; D006801:Humans; D008272:Mafenide / Q000627:therapeutic use; D024802:Nurse's Role; D010146:Pain / Q000209:etiology / Q000517:prevention & control*; D011091:Polyesters / Q000627:therapeutic use; D011095:Polyethylenes / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D012064:Relaxation Therapy; D012837:Silver Sulfadiazine / Q000627:therapeutic use; D017592:Skin Care / Q000379:methods / Q000451:nursing; D013313:Stress Disorders, Post-Traumatic / Q000209:etiology / Q000517:prevention & control
C117408:Acticoat; D000700:Analgesics; D000891:Anti-Infective Agents, Local; D011091:Polyesters; D011095:Polyethylenes; D008272:Mafenide; D002266:Carboxymethylcellulose Sodium; D012837:Silver Sulfadiazine